ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
999
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma [abstract]
Author(s):
K Gardner
,
I. Judson
,
M Leahy
Publication date:
2009
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
999
Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma
Authors:
K Gardner
,
I. Judson
,
M Leahy
Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A California Consortium phase II study
Authors:
SS Ramalingam
,
PC Mack
,
EE Vokes
…
Biomarker correlates from the randomized phase 2 trial of the PARP inhibitor olaparib (O) with or without the antiangiogenic TKI cediranib (C) in recurrent platinum-sensitive ovarian cancer (NCT01116648)
Authors:
See all similar
Cited by
1
Systemic Therapy for Advanced Soft Tissue Sarcomas
Authors:
Richard F. Riedel
See all cited by